Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Co-Diagnostics, Inc. (CODX)

The Class: Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased Co-Diagnostics, Inc. (NASDAQ: CODX) securities between May 12, 2022 and August 11, 2022, for violations of the Securities Exchange Act of 1934.